Images of the brain's fastest signals reveal an electromagnetic marker that predicts a patient's response to a fast-acting antidepressant.
Such use of a brain scanner could someday minimize trial-and-error prescribing and speed delivery of care, say researchers.
Depressed patients showed increased activity in a mood-regulating hub near the front of the brain while viewing flashing frightful faces -- the more the increase, the better their response to an experimental fast-acting medication called ketamine.
Post new comment